Ganglioside-Dependent Generation of a Seed for Alzheimer’s Disease Amyloid

  • Katsuhiko Yanagisawa
Conference paper
Part of the Advances in Behavioral Biology book series (ABBI, volume 57)


Cerebral Amyloid Angiopathy Alzheimer Amyloid ApoE4 Expression Cholera Toxin Subunit Hereditary Cerebral Hemorrhage 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yanagisawa K, Odaka A, Suzuki N, Ihara Y. GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of pre-amyloid in Alzheimer's disease. Nat Med 1995;1:1062–1066.PubMedCrossRefGoogle Scholar
  2. 2.
    Hayashi H, Kimura N, Yamaguchi H, et al. A seed for Alzheimer amyloid in the brain. J Neurosci 2004;24:4894–4902.PubMedCrossRefGoogle Scholar
  3. 3.
    Kakio A, Nishimoto SI, Yanagisawa K, et al. Cholesterol-dependent formation of GM1 ganglioside-bound amyloid β-protein, an endogenous seed for Alzheimer amyloid. J Biol Chem 2001;276:24985–24990.PubMedCrossRefGoogle Scholar
  4. 4.
    Yamamoto N, Igbabvoa U, Shimada Y, et al. Accelerated Aβ aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain. FEBS Lett 2004;569:135–139.PubMedCrossRefGoogle Scholar
  5. 5.
    Yanagisawa K, McLaurin J, Michikawa M, et al. Amyloid β-protein (Aβ) associated with lipid molecules: immunoreactivity distinct from that of soluble Aβ. FEBS Lett 1997;420:43–46.PubMedCrossRefGoogle Scholar
  6. 6.
    Levy E, Carman MD, Fernandez-Madrid IJ, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124–1126.PubMedCrossRefGoogle Scholar
  7. 7.
    Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat Genet 1992;1:218–221.PubMedCrossRefGoogle Scholar
  8. 8.
    Nilsberth C, Westlind-Danielsson A, Eckman CB, et al. The ‘Arctic’ APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation. Nat Neurosci 2001;4:887–893.PubMedCrossRefGoogle Scholar
  9. 9.
    Melchor JP, McVoy L, Van Nostrand WE. Charge alterations of E22 enhance the pathogenic properties of the amyloid β-protein. J Neurochem 2000;74:2209–2212.PubMedCrossRefGoogle Scholar
  10. 10.
    Davis J, Van Nostrand WE. Enhanced pathologic properties of Dutch-type mutant amyloid b-protein. Proc Natl Acad Sci U S A 1996;93:2996–3000.PubMedCrossRefGoogle Scholar
  11. 11.
    Van Nostrand WE, Melchor JP, Ruffini L. Pathologic amyloid b-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells. J Neurochem 1998;70:216–223.PubMedCrossRefGoogle Scholar
  12. 12.
    Yamamoto N, Hirabayashi Y, Amari M, et al. Assembly of hereditary amyloid β-protein variants in the presence of favorable gangliosides. FEBS Lett 2005;579:2185–2190.PubMedCrossRefGoogle Scholar
  13. 13.
    Molander-Melin M, Blennow K, Bogdanovic N, et al. Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains. J Neurochem 2005;92:171–182.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Katsuhiko Yanagisawa
    • 1
  1. 1.National Institute for Longevity SciencesObuJapan

Personalised recommendations